Component: (Network and Table) | |
---|---|
Network | 00100 - Statement - Consolidated Balance Sheets (http://www.diplomat.is/role/StatementConsolidatedBalanceSheets) |
Table | (Implied) |
Reporting Entity [Axis] | 0001610092 (http://www.sec.gov/CIK) |
Consolidated Balance Sheets | Period [Axis] | |
---|---|---|
2016-12-31 | 2015-12-31 | |
Consolidated Balance Sheets | ||
ASSETS | ||
Current assets: | ||
Cash and equivalents | ||
Accounts receivable, net | ||
Inventories | ||
Deferred income taxes | ||
Prepaid expenses and other current assets | ||
Total current assets | ||
Property and equipment, net | ||
Capitalized software for internal use, net | ||
Goodwill | ||
Definite-lived intangible assets, net | ||
Investment in non-consolidated entity | ||
Other noncurrent assets | ||
Total assets | ||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||
Current liabilities: | ||
Accounts payable | ||
Borrowings on line of credit | ||
Short-term debt, including current portion of long-term debt | ||
Accrued expenses: | ||
Compensation and benefits | ||
Contingent consideration | ||
Other | ||
Total current liabilities | ||
Long-term debt, less current portion | ||
Deferred income taxes | ||
Total liabilities | ||
Commitments and contingencies | ||
Shareholders' equity: | ||
Preferred stock (10,000,000 shares authorized; none issued and outstanding) | ||
Common stock (no par value; 590,000,000 shares authorized; 66,764,999 and 64,523,864 shares issued and outstanding at December 31, 2016 and 2015, respectively) | ||
Additional paid-in capital | ||
Retained earnings | ||
Total Diplomat Pharmacy shareholders' equity | ||
Noncontrolling interests | ||
Total shareholders' equity | ||
Total liabilities and shareholders' equity |